EUVIMEDEUVIMED entdecken
Crossref

Comparison of the Clinical Efficacy of Tamsulosin and Solifenacin in Patients with Double-J Stent-Related Symptoms

Rushabhkumar Somani

International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)

DOI: 10.25258/ijcpr.18.7.164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Rushabhkumar Somani.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Double-J (DJ) ureteral stent–related symptoms significantly reduce patients' quality of life after endourological procedures. Common symptoms include hematuria, urinary urgency, frequency, dysuria, flank pain, and irritative lower urinary tract symptoms. Although ureteral stents are essential for maintaining urinary drainage and promoting postoperative recovery, these adverse effects often require pharmacological management. α-Adrenergic blockers and antimuscarinic agents, particularly tamsulosin and solifenacin, are commonly prescribed because they are effective, convenient once-daily therapies, and relatively inexpensive. Therefore, comparing their efficacy in alleviating DJ stent-related symptoms is clinically important.

Objectives

To comparatively evaluate the therapeutic efficacy of tamsulosin and solifenacin in ameliorating symptoms associated with indwelling Double-J ureteral stents. Methodology: This quasi-experimental study includes total of 50 patients who received ureteral stents after ureteroscopic lithotripsy were included and purposively allocated into two treatment groups. Group A comprised 25 patients who received tamsulosin, while Group B included 25 patients treated with solifenacin. Participant selection was performed according to predefined inclusion and exclusion criteria using a purposive sampling technique.

Results

The mean age of participants was 40.08 ± 7.798 years in Group A and 37.84 ± 10.063 years in Group B. Male patients predominated in both treatment groups. Assessment performed on the third postoperative day (T1) demonstrated no statistically significant intergroup differences in total International Prostate Symptom Score (IPSS), irrigative IPSS subscore, Quality of Life (QOL) score, or Visual Analogue Scale (VAS) pain score (P > 0.05). However, subsequent evaluation revealed a statistically significant improvement in the tamsulosin group compared with the solifenacin group. The mean total IPSS, irrigative IPSS subscore, and QOL score were 5.28, 3.15, and 2.50, respectively, in Group A, compared with 6.40, 4.10, and 2.90 in Group B (P < 0.05). Furthermore, the severity of stent-related flank pain was significantly lower among patients receiving tamsulosin than among those treated with solifenacin (mean VAS score: 2.45 vs. 2.64; P < 0.05).

Conclusion

The present investigation was undertaken to compare the clinical effectiveness of tamsulosin and solifenacin in mitigating symptoms associated with indwelling DJ ureteral stents. The findings indicate that tamsulosin provides superior symptomatic relief compared with solifenacin, thereby representing a more effective pharmacological option for the management of DJ stent-related symptoms.

Zitieren

APA

Somani, R. (2026). Comparison of the Clinical Efficacy of Tamsulosin and Solifenacin in Patients with Double-J Stent-Related Symptoms. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.164

Vancouver

Somani R. Comparison of the Clinical Efficacy of Tamsulosin and Solifenacin in Patients with Double-J Stent-Related Symptoms. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.164

BibTeX
@article{Somani2026,
  author = {Somani, Rushabhkumar},
  title = {Comparison of the Clinical Efficacy of Tamsulosin and Solifenacin in Patients with Double-J Stent-Related Symptoms},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {07},
  doi = {10.25258/ijcpr.18.7.164}
}
Kostenlos starten →